iifl-logo-icon 1

Dr Reddys Laboratories Ltd Profit & Loss Statement

1,151.8
(-1.64%)
Feb 21, 2025|03:31:03 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

14,405.2

13,349.1

11,850.4

9,359.3

yoy growth (%)

7.91

12.64

26.61

-3.7

Raw materials

-5,045.9

-4,123

-3,573.8

-2,631

As % of sales

35.02

30.88

30.15

28.11

Employee costs

-2,434.6

-2,270.1

-2,030.2

-1,843

As % of sales

16.9

17

17.13

19.69

Other costs

-4,330.6

-3,819.2

-3,376.8

-3,555.4

As % of sales (Other Cost)

30.06

28.61

28.49

37.98

Operating profit

2,594.1

3,136.8

2,869.6

1,329.9

OPM

18

23.49

24.21

14.2

Depreciation

-814.3

-835

-789.2

-774.1

Interest expense

-38

-46.7

-47.8

-62.8

Other income

482

801.1

743.2

204

Profit before tax

2,223.8

3,056.2

2,775.8

696.99

Taxes

-600.6

-869.8

161.9

-130.1

Tax rate

-27

-28.46

5.83

-18.66

Minorities and other

0

0

0

0

Adj. profit

1,623.2

2,186.4

2,937.7

566.89

Exceptional items

0

0

0

0

Net profit

1,623.2

2,186.4

2,937.7

566.9

yoy growth (%)

-25.75

-25.57

418.2

-59.04

NPM

11.26

16.37

24.78

6.05

Dr Reddys Labs : related Articles

Dr Reddy’s Laboratories Q3 net profit zooms ~3%
24 Jan 2025|10:23 AM

The company logged a growth of 15.9% in its revenue from operations at ₹8,358.60 Crore versus ₹7,215 Crore in Q3FY24.

Read More
Top Stocks for Today - 24th January 2025
24 Jan 2025|07:50 AM

Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.

Read More
Top Stocks for today - 6th December 2024
6 Dec 2024|09:14 AM

Here are some of the stocks that may see significant price movement today: Dr Reddy’s Laboratories, RITES, Canara Bank, etc.

Read More
Dr Reddy’s launches first immuno-onco drug in India
28 Nov 2024|03:43 PM

Dr Reddy's already signed a license and commercialisation deal for Toripalimab with Shanghai Junshi Biosciences Co. Ltd in 2023.

Read More
Dr Reddy’s Bollaram Facility Receives USFDA Form 483 with 7 Observations
21 Nov 2024|11:14 PM

Dr Reddy’s Laboratories shares has gained a total of 5.62% in the last one year, and 2.45% since the beginning of the year.

Read More
Top Stocks for today - 21st November 2024
21 Nov 2024|07:53 AM

Here are some of the stocks that may see significant price movement today: UPL, Tata Power, JSW Steel, Dr Reddy’s, etc.

Read More
Dr Reddy’s posts 15% y-o-y decline in Q2 net profit at ₹1,255 Crore
6 Nov 2024|09:25 AM

EBITDA for the quarter increased 5% year-on-year to ₹2,280 Crore between July and September 2024, while margins improved modestly to 28.4%.

Read More
Top stocks for today - 6th November 2024
6 Nov 2024|08:08 AM

Here are some of the stocks that may see significant price movement today: Dr Reddy’s, Hindustan Zinc, Titan Company, etc.

Read More
Top 10 stocks for today – 11th October, 2024
11 Oct 2024|08:56 AM

Here are some of the stocks that may see significant price movement today: Mazagon Dock Shipbuilders, Krsnaa Diagnostics, Dr Reddy's, etc.

Read More
Dr Reddy’s subsidiary gets positive outcome for CAR-T cell trial
9 Oct 2024|03:48 PM

The experiment also had a favourable safety profile, with no serious adverse effects such as Cytokine Release Syndrome (CRS) or neurotoxicity reported.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.